Patents by Inventor Irine Zolotukhin

Irine Zolotukhin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of pseudotyped recombinant AAV virions
    Publication number: 20070015238
    Abstract: Vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes and Adenovirus transcription products that provide helper functions were used to produce pseudotyped recombinant AAV (rAAV) virions. Purification methods generated pseudotyped rAAV virion stocks that were 99% pure with titers of 1×1012?1×1013 vector genomes/ml.
    Type: Application
    Filed: June 5, 2003
    Publication date: January 18, 2007
    Inventors: Richard Snyder, Sergie Zolotukhin, Yoshihisa Sakai, Barry Byrne, Mark Potter, Irine Zolotukhin, Scott Loiler, Vince Chiodo, Nicholas Muzyczka, William Hauswirth, Terence Flotte, Corinna Burger, Edgardo Rodriguez
  • Production of pseudotyped recombinant AAV virions
    Patent number: 7094604
    Abstract: Vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes and Adenovirus transcription products that provide helper functions were used to produce pseudotyped recombinant AAV (rAAV) virions. Purification methods generated pseudotyped rAAV virion stocks that were 99% pure with titers of 1×1012–1×1013 vector genomes/ml.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: August 22, 2006
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Richard O. Snyder, Sergei Zolotukhin, Yoshihisa Sakai, Barry J. Byrne, Mark R. Potter, Irine Zolotukhin, Scott Loiler, Vince A. Chiodo, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, Corinna Burger, Edgardo Rodriguez, Kevin R. Nash, Thomas J. Fraites
  • Production of pseudotyped recombinant AAV virions
    Publication number: 20040209245
    Abstract: Vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes and Adenovirus transcription products that provide helper functions were used to produce pseudotyped recombinant AAV (rAAV) virions. Purification methods generated pseudotyped rAAV virion stocks that were 99% pure with titers of 1×1012-1×1013 vector genomes/ml.
    Type: Application
    Filed: March 11, 2004
    Publication date: October 21, 2004
    Inventors: Richard O. Snyder, Sergei Zolotukhin, Yoshihisa Sakai, Barry J. Byrne, Mark R. Potter, Irine Zolotukhin, Scott Loiler, Vince A. Chiodo, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, Corinna Burger, Edgardo Rodriguez, Kevin R. Nash, Thomas J. Fraites